Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BODITECH

Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. Its products include automatic ... read more Featured Products: More products

Download Mobile App





Boditech Highlights Automated Benchtop and Handheld Immunoassay Readers at MEDICA 2022

By LabMedica International staff writers
Posted on 15 Nov 2022

Boditech Med (Gang-won-do, Korea) is presenting its portfolio of latest IVD solutions, including TDM, AMS, and TB diagnostic tests, at this year's MEDICA, the world's largest annual medical technology trade fair, which is taking place from 14-17 November in Düsseldorf, Germany.

At MEDICA 2022, Boditech is showcasing the AFIAS-1 immunoassay analyzer with an all-in-one cartridge system. The AFIAS-1 is a compact, single channel lateral flow immunoassay platform with a disposable cartridge that includes all the reagents necessary for the test. Also on display is the Boditech Quick COVID-19 Ag Nasal quick and simplified rapid test kit that determine COVID-19 antigen with a nasopharyngeal or nasal swab. Boditech Quick COVID-19 Ag Nasal can help to quickly and accurately determine the presence or absence of SARS-CoV-2 antigen at anytime and anywhere. It is very useful as a screening test for SARS-CoV-2 virus infection (COVID-19).

Among its other diagnostic tests, Boditech is highlighting the Alpha-Fetoprotein (AFP) test for diagnosing cancers (liver, testicles and ovaries) & monitoring the therapeutic effect. High levels of AFP in adults may indicate the possibility of the liver, the ovaries, or the testicles, as well as noncancerous liver diseases such as cirrhosis and hepatitis. The AFP plus measures the level of AFP to help diagnose or rule out related abnormalities. Visitors to Boditech’s booth at MEDICA 2022 can also get insights into the company’s AFIAS MxA/CRP combo test that assists in diagnosing viral & bacterial infections by measuring virus-specific markers and CRP simultaneously. The AFIAS MxA/CRP combo test is available on the company’s AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10 instruments to support the diagnosis of viral and/or bacterial infection. Boditech has also announced that it will be officially launching its new ichroma Cyfra21-1 which is a tumor marker of NSCLC (non-small cell lung cancer) in early December.

Related Links:
Boditech Med

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.